Michael R. McAlevey - 28 Jan 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Chief Legal Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
28 Jan 2022
Net transactions value
$0
Form type
4
Filing time
01 Feb 2022, 18:29:13 UTC
Previous filing
01 Feb 2022
Next filing
03 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +13,860 $0.000000 13,860 28 Jan 2022 Common Stock 13,860 $236.61 Direct F1
transaction HCA Stock Appreciation Right Award $0 +13,170 $0.000000 13,170 28 Jan 2022 Common Stock 13,170 $236.61 Direct F2
transaction HCA Restricted Stock Units Award $0 +3,880 $0.000000 3,880 28 Jan 2022 Common Stock 3,880 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.
F2 The stock appreciation rights vest in two equal annual installments beginning on January 28, 2023.
F3 Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.
F4 The restricted stock units vest in two equal annual installments beginning on January 28, 2023.